Syndax Pharmaceuticals, Inc.
SNDX
$24.06
$0.562.38%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -68.01M | -60.72M | -71.85M | -84.85M | -94.17M |
| Total Depreciation and Amortization | 3.00K | 3.00K | -- | -- | 0.00 |
| Total Amortization of Deferred Charges | -1.00K | 62.00K | 55.00K | 112.00K | 30.00K |
| Total Other Non-Cash Items | 10.28M | 13.49M | 10.75M | 7.00M | 9.57M |
| Change in Net Operating Assets | -11.76M | -23.38M | -26.75M | -17.43M | 27.19M |
| Cash from Operations | -69.49M | -70.54M | -87.80M | -95.16M | -57.39M |
| Capital Expenditure | -56.00K | -131.00K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 81.63M | 72.56M | 41.89M | 94.14M | -268.97M |
| Cash from Investing | 81.58M | 72.43M | 41.89M | 94.14M | -268.97M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5.92M | 6.28M | 551.00K | 930.00K | 3.77M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 343.65M |
| Cash from Financing | 5.92M | 6.28M | 551.00K | 930.00K | 347.43M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 18.01M | 8.17M | -45.36M | -90.00K | 21.06M |